Literature DB >> 19458498

Locked nucleic acid as a novel class of therapeutic agents.

Rakesh N Veedu1, Jesper Wengel.   

Abstract

Locked Nucleic Acid (LNA) is a nucleic acid analogue with unprecedented binding affinity and excellent specificity toward complementary RNA and DNA oligonucleotides. The remarkable properties of LNA have led to applications within various gene silencing strategies both in vitro and in vivo. In the present review, we highlight the uses of LNA for regulation of gene expression with emphasis on RNA targeting.

Mesh:

Substances:

Year:  2009        PMID: 19458498     DOI: 10.4161/rna.6.3.8807

Source DB:  PubMed          Journal:  RNA Biol        ISSN: 1547-6286            Impact factor:   4.652


  39 in total

1.  An antisense microwalk reveals critical role of an intronic position linked to a unique long-distance interaction in pre-mRNA splicing.

Authors:  Natalia N Singh; Katrin Hollinger; Dhruva Bhattacharya; Ravindra N Singh
Journal:  RNA       Date:  2010-04-22       Impact factor: 4.942

2.  PEI-complexed LNA antiseeds as miRNA inhibitors.

Authors:  Maren Thomas; Kerstin Lange-Grünweller; Eyas Dayyoub; Udo Bakowsky; Ulrike Weirauch; Achim Aigner; Roland K Hartmann; Arnold Grünweller
Journal:  RNA Biol       Date:  2012-08-01       Impact factor: 4.652

3.  Mimicking the inflammatory cell adhesion cascade by nucleic acid aptamer programmed cell-cell interactions.

Authors:  Weian Zhao; Weili Loh; Ilia A Droujinine; Weisuong Teo; Namit Kumar; Sebastian Schafer; Cheryl H Cui; Liang Zhang; Debanjan Sarkar; Rohit Karnik; Jeffrey M Karp
Journal:  FASEB J       Date:  2011-06-07       Impact factor: 5.191

4.  ErbB3 ablation impairs PI3K/Akt-dependent mammary tumorigenesis.

Authors:  Rebecca S Cook; Joan T Garrett; Violeta Sánchez; Jamie C Stanford; Christian Young; Anindita Chakrabarty; Cammie Rinehart; Yixian Zhang; Yaming Wu; Lee Greenberger; Ivan D Horak; Carlos L Arteaga
Journal:  Cancer Res       Date:  2011-04-11       Impact factor: 12.701

Review 5.  MicroRNAs in metabolism and metabolic disorders.

Authors:  Veerle Rottiers; Anders M Näär
Journal:  Nat Rev Mol Cell Biol       Date:  2012-03-22       Impact factor: 94.444

6.  Regulation of the apolipoprotein gene cluster by a long noncoding RNA.

Authors:  Paul Halley; Beena M Kadakkuzha; Mohammad Ali Faghihi; Marco Magistri; Zane Zeier; Olga Khorkova; Carlos Coito; Jane Hsiao; Matthew Lawrence; Claes Wahlestedt
Journal:  Cell Rep       Date:  2014-01-02       Impact factor: 9.423

7.  Selection, optimization, and pharmacokinetic properties of a novel, potent antiviral locked nucleic acid-based antisense oligomer targeting hepatitis C virus internal ribosome entry site.

Authors:  Carl Laxton; Kevin Brady; Sterghios Moschos; Paul Turnpenny; Jaiessh Rawal; David C Pryde; Ben Sidders; Romu Corbau; Chris Pickford; E J Murray
Journal:  Antimicrob Agents Chemother       Date:  2011-04-18       Impact factor: 5.191

8.  Cellular localization and allele-selective inhibition of mutant huntingtin protein by peptide nucleic acid oligomers containing the fluorescent nucleobase [bis-o-(aminoethoxy)phenyl]pyrrolocytosine.

Authors:  Jiaxin Hu; David W Dodd; Robert H E Hudson; David R Corey
Journal:  Bioorg Med Chem Lett       Date:  2009-09-06       Impact factor: 2.823

9.  Antisense-mediated reduction of proprotein convertase subtilisin/kexin type 9 (PCSK9): a first-in-human randomized, placebo-controlled trial.

Authors:  Eveline P van Poelgeest; Michael R Hodges; Matthijs Moerland; Yann Tessier; Arthur A Levin; Robert Persson; Marie W Lindholm; Kamille Dumong Erichsen; Henrik Ørum; Adam F Cohen; Jacobus Burggraaf
Journal:  Br J Clin Pharmacol       Date:  2015-10-24       Impact factor: 4.335

10.  Inhibition of microRNA miR-92a induces apoptosis and inhibits cell proliferation in human acute promyelocytic leukemia through modulation of p63 expression.

Authors:  Mohammadreza Sharifi; Rasoul Salehi; Yousof Gheisari; Mohammad Kazemi
Journal:  Mol Biol Rep       Date:  2014-01-31       Impact factor: 2.316

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.